FDA approves weight-loss drug to treat sleep apnea

By The Hill | Created at 2024-12-21 13:41:07 | Updated at 2024-12-21 17:43:16 4 hours ago

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use, approving a prescription medicine suited for adults suffering from moderate to severe obstructive sleep apnea (OSA)…

Read Entire Article